Related Experiment Video
Updated: May 17, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
[Participation of damage-associated molecular patterns in conventional treatment of cancer]
Verónica Rojo-León1, Dolores Aguilar-Cázares, Heriberto Prado-García
1Laboratorio de Cáncer Pulmonar, Unidad de Investigación, Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas.
Abstract:
Cells of the innate immune system are involved in discriminating between the innocuous cell death (apoptosis) which occurs in tissues during homeostasis, and the cell death associated to tissue damage (necrosis). Recently, a new variant of apoptosis termed immunogenic apoptosis has been described. In cancer, this type of cell death has acquired great relevance. In vitro and in vivo experimental models support that radiotherapy and some chemotherapeutic drugs induce the immunogenic apoptosis of malignant cells. Dying cells express at cytoplasmic membrane or release several nuclear or intracytoplasmic molecules termed "danger signals" or damage associated molecular patterns (DAMPs). DAMPs alert the organism and play a role inducing an efficient anti-tumor immune response. In this review, the importance of cell death by immunogenic apoptosis, the cytotoxic drugs that induce this type of cell death, the biologic role of some DAMPs and their participation in the activation of the antitumor immune response, in particular in the phagocytic cell, are indicated. The goal of this information should impact in improving the participation of the immune system in the recognition and efficient elimination of the residual tumor cells and to overcome the evasion mechanisms of tumor cells. This knowledge should lead to a better control of the growth of tumors with a concomitant reduction in the tumor recurrence. Also, an increase in the survival of the cancer patients or probably their definitive cure could be reached in the future.
Insights
Immunogenic apoptosis, a form of cell death, is crucial for anti-tumor immunity. Cancer therapies can induce this cell death, releasing danger signals that activate immune responses against tumors.
Area of Science:
- Immunology
- Cell Biology
- Oncology
Context:
- Innate immune cells distinguish between homeostatic apoptosis and damage-induced necrosis.
- Immunogenic apoptosis, a distinct cell death pathway, is increasingly recognized for its role in cancer.
Purpose:
- To review the significance of immunogenic apoptosis in cancer.
- To discuss cytotoxic drugs that induce this cell death pathway.
- To explore the biological role of damage-associated molecular patterns (DAMPs) in activating anti-tumor immunity.
Summary:
- Radiotherapy and chemotherapy can trigger immunogenic apoptosis in cancer cells.
- Dying cancer cells release DAMPs, which act as danger signals.
- These DAMPs are critical for initiating an effective anti-tumor immune response, particularly involving phagocytic cells.
Impact:
- Enhancing immune recognition and elimination of residual tumor cells.
- Overcoming tumor cell evasion mechanisms.
- Improving tumor growth control, reducing recurrence, and potentially increasing patient survival or achieving cures.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
The Intrinsic Apoptotic Pathway